InterChina Partners, one of leading investment banking advisory firms based in China, is pleased to announce that it advises Genus Plc (“Genus”, LSE: GNS), on its strategic porcine collaboration in China with Beijing Capital Agribusiness Co. Ltd (“BCA”). Under the definitive transaction agreements, BCA will acquire 51% of PIC China (”PICC”) through a share purchase (USD 160 million) and additional subscription for new shares. This transaction cements Genus’s and BCA’s commitment to strengthening PIC China’s local business and achieving PRP¹ commercialization in China. This would allow Chinese pig producers to benefit from this leading technology to improve their productivity. The transaction is completed on 31 January 2026.

About Genus: Headquartered in the United Kingdom, is a global leader in animal genetics, specializing in the improvement of bovine and porcine livestock through advanced biotechnology. The company operates across six continents with worldwide sales in over 85 countries under the trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs), and selected local brands. Principle product offering includes semen, embryos and breeding animals with superior genetics, which are supplied to leading pig and cattle farmers globally.

About PICC: PICC is the wholly owned subsidiary of Genus. PICC supplies and distributes elite porcine genetics to leading Chinese pig producers.

About BCA: Beijing Capital Agribusiness Co., Ltd owns a portfolio of animal genetics businesses and is one of the largest agribusiness groups in China. BCA is owned by Beijing Capital Agribusiness & Foods Group (which is in turn owned by the Beijing Municipality), GLP-Youshan Fund, and CITIC Agriculture Technology Co., Ltd and CITIC Agri Investment Fund.

InterChina’s deal team includes Eric Zhou (Partner), Kevin Xiao (Director), and Yuan Hao (Manager).

“We are delighted to have supported Genus on this complex transaction. The deal will further strengthen PICC’s leading position in the Chinese market and enable Genus to accelerate the commercialization of its PRRS-resistant pig technology in China. We look forward to seeing the success of this partnership between Genus and BCA over the coming years,” said Eric Zhou.

InterChina served as Genus’s sole financial advisor.   

------

¹ PRRS-resistant pig, Porcine reproductive and respiratory syndrome (PRRS) virus, is a virus that causes a disease of pigs, also known as blue-ear pig disease